Literature DB >> 11379350

Hepatocyte growth factor promotes liver regeneration and protein synthesis after hepatectomy in cirrhotic rats.

Y Ogura1, M Hamanoue, G Tanabe, S Mitsue, S Yoshidome, K Nuruki, T Aikou.   

Abstract

BACKGROUND/AIMS: Hepatocyte growth factor, a potent mitogen for hepatocytes has been reported to be a hepatrophic factor in normal livers. In this study, the effect of exogenous hepatocyte growth factor on liver regeneration in cirrhotic rats was investigated, in vitro and in vivo.
METHODOLOGY: Liver cirrhosis was induced by intraperitoneal injections of an emulsion, carbon tetrachloride and olive oil, twice weekly for 10 weeks. In vitro, various amounts of exogenous hepatocyte growth factor; 0, 0.5, 1, 2.5, 5, and 10 ng/mL; were added to the hepatocytes isolated using in situ perfusion method. In vivo, partial hepatectomy (Hx), according to the procedure described by Higgins and Anderson, was performed on cirrhotic rats. Saline solution (control group) or 3 micrograms/kg of exogenous hepatocyte growth factor (HGF group) was then injected through the tail vein at intervals 12 hours after Hx.
RESULTS: In vitro, DNA synthesis in hepatocytes obtained from cirrhotic livers increased following exogenous hepatocyte growth factor in dose-dependent fashion. In vivo, the labeling index of 5-bromo-2'-deoxyuridine at 24 hours after Hx was markedly increased by exogenous hepatocyte growth factor (control, 10.0 +/- 3.1%; hepatocyte growth factor, 25.8 +/- 9.8%; P < 0.01). Furthermore, serum albumin at 24 and 72 hours and a normotest at 24 hours after Hx, were significantly higher in the HGF group than in the control group.
CONCLUSIONS: These results indicate that exogenous hepatocyte growth factor may promote DNA synthesis and protein synthesis during liver regeneration after Hx with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11379350

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

Review 1.  Artificial cell microencapsulated stem cells in regenerative medicine, tissue engineering and cell therapy.

Authors:  Zun Chang Liu; Thomas Ming Swi Chang
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

2.  The administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model.

Authors:  Makoto Matsukubo; Keisuke Yano; Tatsuru Kaji; Koshiro Sugita; Shun Onishi; Toshio Harumatsu; Ayaka Nagano; Mayu Matsui; Masakazu Murakami; Koji Yamada; Waka Yamada; Mitsuru Muto; Kotaro Kumagai; Akio Ido; Satoshi Ieiri
Journal:  Pediatr Surg Int       Date:  2021-01-03       Impact factor: 1.827

3.  Tob1 is a constitutively expressed repressor of liver regeneration.

Authors:  Karen J Ho; Nhue L Do; Hasan H Otu; Martin J Dib; Xianghui Ren; Keiichi Enjyoji; Simon C Robson; Ernest F Terwilliger; Seth J Karp
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

4.  Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy.

Authors:  F Xue; T Takahara; Y Yata; Y Kuwabara; E Shinno; K Nonome; M Minemura; S Takahara; X Li; E Yamato; A Watanabe
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.